Teva Pharmaceuticals Europe Bv

The French Competition Authority Follows up Allegations of Anti-competitive Practices by Sanofi-Aventis to Exclude Fair Generic Competition for Plavix(R) (clopidogrel)

Older News

UTRECHT, The Netherlands, May 19, 2010 - Teva Sant, one of France's leading generic medicines companies, has welcomed news that the French Competition Authority has agreed to its request to investigate alleged anti-competitive practices by Sanofi-Aventis aimed at preventing generic competition to its Plavix(R) (clopidogrel) treatment.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy